Molly Burns Austin, M.D.
Dermatology Physician · Dallas, TX
Molly Burns Austin, M.D. is a dermatology physician with a practice address in Dallas, Texas, and NPI 1639435720, issued on Apr 3, 2012. Check the license (Texas Q1791, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Molly Burns Austin
- Credential
- M.D.
- Primary taxonomy
- Dermatology Physician 207N00000X
- License number
- Q1791 TX
Self-reported in NPPES; status is on the state search - Practice location
- 9301 N Central Expy Ste 470, Dallas, TX 75231
- Phone
- (214) 506-1115
- Enumerated
- Apr 3, 2012
- Record last updated
- Jun 18, 2019 (not updated in 7 years: call before relying on the address or phone)
- Fax
- (214) 435-6688
- Medicare enrollment
- Enrolled (PECOS I20151016000698); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest dermatology physician records → All 1,172 in Texas → Look up another NPI →
Also registered at 9301 N Central Expy Ste 470
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Stacy Kasitinon, MD, PHDDermatology Physician1467030023
- Claire Reddick, M.D.Dermatology Physician1689870735
- Tori Walker, PA-CPhysician Assistant1811323108
Verify Molly Burns Austin in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license Q1791Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
86% fewer Medicare Part D claims than the average dermatology physician in 2024
108 Medicare Part D claims for 52 beneficiaries, against an average of 797 among the 12,802 providers of this specialty who prescribed in Part D. Brand-name drugs were 24% of claims.
Most prescribed
- Clobetasol Propionate18 claims
- Doxycycline Hyclate16 claims
- Dupixent Pen13 claims
- Dupixent Syringe12 claims
- Minoxidil11 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $1,757.90
93 payments; by number, the most common kind was food and beverage; the largest payer was Abbvie Inc. The 10,250 providers of this specialty with any payment received $8,544.61 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Austin And Reddick Dermatology PLLCDallas, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Molly Burns Austin among 1,172 dermatology physician records in Texas
Molly Burns Austin, M.D. is one of 1,172 dermatology physician records with a practice address in Texas. 88% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2012, is newer than 60% of them.
- NPI issued2012 · 60% of these records are older, 36% newer
- In a Medicare fileYes · 88% of these records are
- In the CMS Doctors and Clinicians fileYes · 79% of these records are
- Graduated2011 · median 2008 among the 926 with a school on file
- Record last updated2019 · 48% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207N00000X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Dermatology Physician providers in Texas
There are 1,172 dermatology physician records in Texas.
All 1,172 in Texas → Every provider in Dallas → Dermatology Physician nationwide →
The 8 dermatology physician records with the nearest ZIP codes
- Nnenna Agim, MDDallas, TX 752311962603639
- Jennifer Cather, M.D.Dallas, TX 752311154366417
- Jeri Foshee, M.D.Dallas, TX 752311710026604
- Peter Hino, M.D.Dallas, TX 752311053407296
- Mary Hurley, M.D.Dallas, TX 752311316057748
- Martin Kassir, M.D.Dallas, TX 752311225180979
- Flora Kim, MDDallas, TX 752311699905372
- Rebecca Marcus, M.D.Dallas, TX 752311821257189
Common questions
What is Molly Burns Austin, M.D.'s NPI number?
Molly Burns Austin, M.D.'s National Provider Identifier (NPI) is 1639435720, issued on Apr 3, 2012. An NPI identifies a provider in billing; it is not a license.
Where is Molly Burns Austin, M.D. located?
The NPPES record lists a practice address at 9301 N Central Expy Ste 470, Dallas, TX, 75231. Phone: (214) 506-1115. Providers update this record themselves, so call before visiting.
How can I verify Molly Burns Austin, M.D.'s license?
NPPES lists Texas license number Q1791, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Molly Burns Austin, M.D. prescribe under Medicare Part D?
In 2024, Molly Burns Austin, M.D. had 108 Medicare Part D claims for 52 beneficiaries; the average among dermatology physician prescribers was 797. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.